Open for recruitment
Trial summary
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts – phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
Trial details
Short title
LOXO-FRA-24001 / J5E-OX-JZXA
Diagnosis
Advanced solid tumours
Type of treatment
Medical Oncology
Phase
Ia/b
Locations
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.